14-day Premium Trial Subscription Sign Up For FreeGet Free

Collegium Pharmaceutical Stock Forecast NASDAQ:COLL

Price Target and Analyst Ratings

Most Recent Rating

On September 10, 2021 "Needham & Company LLC" gave "$32.00" rating for COLL. The price target was set to $19.700.0%.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-09-10 $32.00 Initiated by Needham & Company LLC $19.70 $19.700.0%
2021-08-27 $32.00 Initiated by Needham & Company LLC $20.41 $20.410.0%
2021-08-06 $34.00 - $32.00 Target Lowered by Needham & Company LLC $20.54 $20.50→17.5%
2021-08-06 Downgraded by Cantor Fitzgerald $20.54 $24.84→0.4%
2021-08-06 $33.00 - $28.00 Target Lowered by HC Wainwright $20.54 $24.84→0.4%
2021-07-16 $34.00 Initiated by Needham & Company LLC $23.89 $23.89+0.0%
2021-07-09 Buy Initiated by Needham & Company LLC $22.57 $34.00
2021-07-02 Buy Initiated by Needham & Company LLC $23.30 $34.00
2021-01-11 Buy Target Raised by HC Wainwright $21.18 $29.00 → $33.00
2021-01-11 Buy Reiterated by HC Wainwright $21.18 $29.00 → $33.00
2020-12-29 Buy - Buy Reiterated by Needham & Company LLC $19.94
2020-11-09 Buy Reiterated by HC Wainwright $20.38 $31.00 → $29.00
2020-08-21 Buy Reiterated by Needham & Company LLC $18.84 $34.00
2020-07-24 Buy Initiated by Needham & Company LLC $16.77 $34.00
2020-07-15 Buy Reiterated by Needham & Company LLC $17.36 $34.00
2020-07-14 Sell Initiated by BWS Financial $16.66 $8.00
2020-07-06 Buy Initiated by Needham & Company LLC $17.54 $36.00
2020-06-26 Buy Initiated by Needham & Company LLC $16.34 $36.00
2020-06-19 Buy Initiated by Needham & Company LLC $17.73 $36.00
2020-05-26 Neutral Initiated by Guggenheim $23.43
2020-05-08 Buy Target Lowered by Needham & Company LLC $21.47 $38.00 → $36.00

COLL Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -18.86% during the next 3 months and, with a 90% probability hold a price between $12.88 and $17.95 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2021-09-20 $15.79 $18.92 $22.04
2021-09-21 $15.71 $18.83 $21.96
2021-09-22 $15.63 $18.75 $21.88
2021-09-23 $15.55 $18.67 $21.80
2021-09-24 $15.46 $18.59 $21.72
2021-09-27 $15.38 $18.51 $21.63
2021-09-28 $15.30 $18.43 $21.55
2021-09-29 $15.22 $18.35 $21.47
2021-09-30 $15.14 $18.26 $21.39
2021-10-01 $15.06 $18.18 $21.31
2021-10-04 $14.97 $18.10 $21.23
2021-10-05 $14.89 $18.02 $21.14
2021-10-06 $14.81 $17.94 $21.06
2021-10-07 $14.73 $17.86 $20.98
2021-10-08 $14.65 $17.77 $20.90
2021-10-11 $14.57 $17.69 $20.82
2021-10-12 $14.48 $17.61 $20.74
2021-10-13 $14.40 $17.53 $20.65
2021-10-14 $14.32 $17.45 $20.57
2021-10-15 $14.24 $17.37 $20.49
2021-10-18 $14.16 $17.28 $20.41
2021-10-19 $14.08 $17.20 $20.33
2021-10-20 $13.99 $17.12 $20.25
2021-10-21 $13.91 $17.04 $20.16
2021-10-22 $13.83 $16.96 $20.08
2021-10-25 $13.75 $16.88 $20.00
2021-10-26 $13.67 $16.79 $19.92
2021-10-27 $13.59 $16.71 $19.84
2021-10-28 $13.50 $16.63 $19.76
2021-10-29 $13.42 $16.55 $19.68

About Collegium Pharmaceutical

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes abuse-deterrent products that incorporate its DETERx platform technology for the treatment of chronic pain and other diseases. Its lead product candidate is Xtampza, an oral formulation of oxycodone. The company is also developing COL-195, a hydrocodone for the treatment of chronic pain; COL-172, an oxymorphone for the treatment of chronic pain; COL-19... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT